Archive for December, 2008

Drug Store News - Warner Chilcott files ANDA for terazosin hydrochloride capsules

Wednesday, December 31st, 2008

Warner Chilcott PLC has filed an abbreviated new drug application with the FDA for an AB rateable form of terazosin hydrochloride capsules, said to be a bioequivalent of Abbott Laboratories’ Hytrin alpha blocker.

Related Results

Common prostate drug is ineffective - Hytrin works better - Hytrin vs ProscarMylan receives approval for generic HytrinTorP…

Chain Drug Review - Mylan Approval

Friday, December 26th, 2008

PITTSBURGH — Mylan Laboratories Inc. has received approval from the FDA to manufacture and market terazosin hydrochloride capsules, the generic equivalent to Abbott Laboratories’ Hytrin.

Related Results

Common prostate drug is ineffective - Hytrin works better - Hytrin vs ProscarMylan receives a…

Chain Drug Review - Novartis settles dispute with FTC

Monday, December 22nd, 2008

Geneva Pharmaceuticals Inc., a unit of Novartis AG, has settled claims by the Federal Trade commission that an agreement it has with Abbott Laboratories over the marketing of a generic drug violated antitrust regulations. The case involves a generic version of Abbott’s Hytrin produced by Geneva….

Business Wire - Aphios Awarded SBIR Grant From NCCAM, NIH for Standardized & Improved Saw Palmetto Product

Thursday, December 18th, 2008

Business/Technology Editors & Health/Medical Writers
WOBURN, Mass.–(BW HealthWire)–Oct. 3, 2000
Aphios Corporation has been awarded a SBIR grant from the National Center for Complementary and Alternative Medicine (NCCAM) of the National Institutes of Health (NIH) for developing a standardized and improved Saw Palmetto product.”
Saw Palmetto, derived from the Native Amer…

Business Wire - Mylan Laboratories Settles United Wisconsin Services Suit; Class Action Lawsuit Accused Drug Manufacturer of Unfair Prices on Lorazepam and Clorazepate

Thursday, December 11th, 2008

Business Editors
MILWAUKEE–(BUSINESS WIRE)–Feb. 2, 2001
United Wisconsin Services, Inc., a Milwaukee-based health insurer, has entered into a Stipulation of Settlement with Mylan Laboratories, Inc. which, subject to court approval, will settle class action litigation on behalf of health insurers and other third party payers concerning prices paid in 1998 and 1999 for the generic versions of the prescription drugs lorazepam, and clorazepate.

Nutrition Action Healthletter - Palmetto and the Prostate

Saturday, December 6th, 2008

You find that you no longer can sit through a movie or a long car room. And sometimes when you get there, not much happens.
The problem: a swollen prostate gland, or benign prostatic hypertrophy (BPH). It plagues one out of every two men over the age of 60. If the enlarged gland presses against the urethra, the tube that carries urine from the bladder out of the body, the simple act of ur…